In vivo and in vitro neurotoxic action of plasma ultrafiltrate from uraemic patients

Nephrology Dialysis Transplantation

Volumn 13, Issue 9, 1998, Pages 2288-2293

  Cantaro, Salvatore ^a,d   Zara, Gabrielle ^a   Battaggia, Claudie ^b   Di Loreto, Pier Luigi ^a   Calò, Lorenzo ^a   D'Angelo, Angela ^a   Theophilidis, George ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b Department of Neurotraumatology   (Italy)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d Istituto di Medicina Interna di Padova   (Italy)

Author keywords

Dialysis; Neuropathy; Polysulphone membranes; Uraemia

Indexed keywords

ACTION POTENTIAL; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASE REPORT; CONTROLLED STUDY; DOSE RESPONSE; EVOKED MUSCLE RESPONSE; FEMALE; FROG; HEMODIALYSIS; HUMAN; MALE; MOTOR PERFORMANCE; NERVE CONDUCTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; ULTRAFILTRATION; UREMIA; UREMIC POLYNEUROPATHY;

ACTION POTENTIALS; AGED; ANIMALS; ANURA; EVOKED POTENTIALS; FEMALE; HEMOFILTRATION; HUMANS; INJECTIONS; MUSCLE, SKELETAL; NEURAL CONDUCTION; NEUROTOXINS; PLASMA; RATS; SCIATIC NERVE; TIME FACTORS; UREMIA;

EID: 0031670570     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.9.2288     Document Type: Article

References (30)

1. Fraser CL, Arieff AI. Nervous system complications in uremia. Ann Intern Med 1988; 109: 143-153
2. Mahoney CA, Arieff AI. Central and peripheral nervous system effects of chronic renal failure. Kidney Int 1983; 24: 170-177
3. Campese VM, Romoff MS, Levitan D, Lane K, Massry SG. Mechanism of autonomic nervous system dysfunction in uremia. Kidney Int 1981; 20: 246-253
4. Raskin NH, Fishman RA. Neurologic disorders in renal failure. N Engl J Med 1976; 294: 143-148 and 204-210
5. Nielsen VK. The peripheral nerve function in chronic renal failure: a survey. Acta Med Scand 1974; 169: 7-32
6. Asbury AK. Ureraic neuropathy. In: Dick PJ, Thomas PK, Lambert EH, ed. Peripheral Neuropathy (vol. 2)., Saunders, Philadelphia, 1975; 982-992
7. Spencer PS, Schaumberg HH. Central-peripheral distal axonopathy pathology of 'dying-back' polyneuropathies. Progr Neuropathol 1977; 3: 255-295
8. Schaumberg HH, Spencer PS. Toxic neuropathies. Neurology 1979; 29: 429-431
9. McQuillen MP, Gorin FJ. Serial ulnar nerve conduction velocity measurements in normal subjects. J Neurol Neurosurg Psychiatry 1969; 32: 14-18
10. Nielsen VK. The peripheral nerve function in chronic renal failure. VI. The relationship between sensory and motor nerve conduction and kidney function, azotemia, age, sex, and clinical neuropathy. Acta Med Scand 1973; 195: 445-462
11. Theophilidis G, Pavlidou F. The viability of the sciatic nerve of the frog and rat in a chamber which allows maintained in vitro recording of the compound nerve action potential. Muscle Nerve 1993; 7: 113-114
12. Theophilidis G, Benaki M, Papadopoulou-Mourkidou F. Neurotoxic action of six pyrethroid insecticides on the isolated sciatic nerve of a frog (Rana ridibunda). Comp Biochem Physiol [C] (in press)
13. Dyck PJ, Johnson WJ, Lambert EH, O'Brien PC. Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc 1971; 46: 400-431
14. Giovannetti S, Balestri PL, Barsotti G. Methylguanidine in uremia. Arch Intern Med 1973; 131: 709-713
15. Reznek RH, Salway JG, Thomas PK. Plasma myoinositol concentration in uraemic neuropathy. Lancet 1977; 1: 675-676
16. Akmal M, Massry GM. Role of parathyroid hormone in the decreased motor nerve conduction velocity of chronic renal failure. Proc Soc Exp Biol Med 1990; 195: 202-207
17. Babb AL, Ahmad S, Bergstrom J, Scribner BH. The middle molecules hypothesis in perspective. Am J Kidney Dis 1981; 1: 46-50
18. Bolton CF. Electrophysiologic changes in uremic neuropathy after successful renal transplantation. Neurology 1976; 26: 152-161
19. Danziger CH. Uraemic neuropathy and treatment with renal transplantation. ANNA J 1989; 16: 67-70
20. Uncini A, Santoro M, Corbo M, Lugaresi A, Latov N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GMI antibodies. Muscle Nerve 1993; 31: 610-615
21. Armstrom A, Persson NH. Some pharmacological properties of o-Methylpropylaminopropionanilide, a new local anaesthetic. Br J Pharmacol 1961; 16: 32-44
22. Geronikaki A, Theophilidis G. Synthesis of 1-(amino acetylamino) thiazole derivatives and comparison of their local anaesthetic activity by the method of action potential. Eur J Med Chem 1992; 27: 1-8
23. Pakhomov AG, Dubovick BV, Kolupayev VE. Pronkevich AN. Effects of high-peak-power microwave pulses on isolated nerve function. Electro- Magnetobiol 1993; 12: 1-15
24. Gaffey CT. The response of maximal and submaximal action potentials from frog sciatic nerve to 200 kV X-rays. Radiat Res 1971; 45: 311-325
25. Van der Bercken I. The action of allethrin on the peripheral nervous system of frog. Peat Sci 1977; 8: 692-699
26. Snyder RE, Smith RS. A multiwire proportional chamber study of axoplasmic transport in frog sciatic nerve involving interruption of somatic supply. Brain Res 1979; 161: 237-251
27. Malberti F, Surian M, Farina M et al. Effect of hemodyalisis and hemofiltralion on uremic neuropathy. Blood Purif 1991; 9: 285-295
28. Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity and potential economic impact in a community. N Engl J Med 1980; 303: 189-194
29. Dinn JJ, Crane DL. Schwann cell dysfunction in uraemia. J Neurol Neurosurg Psychiatry 1970; 33: 605-608
30. Dyck PJ, Johnson WJ, Lambert EH, O'Brien PC. Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Proc Mayo Clin 1971; 46: 400-431